APMA GRANTS SEAL OF APPROVAL FOR JUBLIA TOPICAL SOLUTION 10%

Bausch Health Companies Inc. ("Bausch Health") and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology healthcare businesses, has announced JUBLIA® (efinaconazole) Topical Solution, 10%, a treatment for onychomycosis, a fungal infection of the toenails, has received the American Podiatric Medical Association (APMA) Seal of Approval. The APMA Seal of Approval is granted to products that promote good foot health and are of significant value when used in a consistently applied program of daily foot care and regular professional treatment.

 

Dr. Jeffrey DeSantis

 

"Toenail fungus is extremely common, but it is an infection—and a highly contagious infection," said Jeffrey R. DeSantis, DPM, president of the American Podiatric Medical Association. "APMA is proud to bestow its Seal of Approval on products such as JUBLIA® that meet our physicians' highest standards for safety and effectiveness."

 

Source: KBTX [12/6/21]

Courtesy of Barry Block, editor of PM News